Last quarter (Q4 2022), Life Science Reit Plc's total revenue was £―, a decrease of ― from previous quarter. In Q4, Life Science Reit Plc's net income was £―. See Life Science Reit Plc’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21
Total Revenue	-	£ -19.92M	£ 8.12M
Credit Losses Provision	-	-	-
Non Interest Expense	-	-	-
Incomefrom Associatesand Other Participating Interests	-	-	-
Special Income Charges	-	-	-
Pretax Income	-	£ -27.47M	£ 7.74M
Tax Provision	-	£ 146.00K	£ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-
Net Income Common Stockholders	-	£ -27.61M	£ 7.74M
Basic EPS	-	£ -0.08	£ 0.02
Diluted EPS	-	£ -0.08	£ 0.02
Basic Average Shares	-	£ 350.00M	£ 350.00M
Diluted Average Shares	-	£ 350.00M	£ 350.00M
Dividend Per Share	-	£ 0.01	-
Reported Normalized Basic E P S	-	£ <0.01	£ >-0.01
Reported Normalized Diluted E P S	-	-	-
Rent Expense Supplemental	-	-	-
Interest Income After Provision For Loan Loss	-	-	-
Net Income From Continuing And Discontinued Operation	-	£ -27.61M	£ 7.74M
Normalized Income	-	£ -8.83M	£ -295.00K
Total Money Market Investments	-	-	-
Ebit	-	-	-
Ebitda	-	-	-

Currency in GBP

Life Science Reit Plc Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing